This inventor holds 1 USPTO granted patent. Top assignee: Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung. Active years: 1982.
Company Filing History:
Years Active: 1982
Title: Albert Reuter: Innovator in Cardiotonics
Introduction
Albert Reuter is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that serve as cardiotonics. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving health outcomes.
Latest Patents
Reuter holds a patent for "6-Hydroxy-2-phenyl-imidazo[4,5-b]pyridines and salts thereof." This patent includes compounds of the formula wherein R is methylsulfinyl or methylsulfonyl, along with their 3H-tautomers and non-toxic, pharmacologically acceptable acid addition salts. These compounds are recognized for their utility as cardiotonics, highlighting Reuter's focus on cardiovascular health.
Career Highlights
Albert Reuter is associated with Dr. Karl Thomae Gesellschaft mit beschränkter Haftung, where he has been able to apply his innovative ideas in a collaborative environment. His work has not only contributed to the company's portfolio but has also advanced the field of cardiology through his research and development efforts.
Collaborations
Reuter has worked alongside notable colleagues such as Willi Diederen and Axel Prox. Their collaborative efforts have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Albert Reuter's contributions to the field of cardiotonics through his patent and collaborative work exemplify his commitment to innovation in pharmacology. His achievements reflect the importance of research and development in improving health outcomes.